Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Usability and pharmacokinetics of sarilumab auto-injector versus prefilled syringe in rheumatoid arthritis
2012-004339-21Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sarilumab in rheumatoid arthritis (RA) (2 arms), sponsored by Sanofi. Primary endpoint: Number of validated AID-associated product technical failures. Started Apr 2014; status: completed.
02
Drugs
sarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2012-004339-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004339-21.